A new era in cancer research

Discoveries that offer hope

Cancer research at Université de Montreal and its affiliated institutions encompasses the entire discovery chain of drugs and treatments.

IRIC researchers

Researchers at the Institute for Research in Immunology and Cancer (IRIC) work to shed light on the mechanisms of cancer and speed up the discovery of new cancer therapies.

Anne MARINIER

MEDICAL CHEMISTRY

Claude PERREAULT

IMMUNOBIOLOGY

Guy SAUVAGEAU

HEMATOLOGY

Michel BOUVIER

PHARMACOLOGY

Sébastien LEMIEUX

BIOINFORMATICS

Delphine BOUILLY

BIOPHYSICS

udemnouvelles

18 September 2024

Sylvain Meloche's team has created a preclinical model to study hepatocellular carcinoma, the most common subtype of liver cancer, in order to develop new targeted therapies.

4 September 2024

A study by UdeM professor Claude Perreault's team at IRIC proposes three potential functions for so-called parasite DNA sequences in T cell development.

7 August 2024

This summer, UdeM is helping roll out a program across Quebec to reduce the side effects of treatment for children recently diagnosed with cancer.

1 August 2024

The innovative approach to long-term hypoxia employed by Étienne Gagnon's team has led to the identification of a potential new marker for ovarian cancers.

All news

Partnerships that accelerate new discoveries

Our research environments are firmly interdisciplinary and have solid ties to clinical practice. This speeds up the development of cancer therapies and gives new hope to patients and their families.

A pool of renowned researchers

Our researchers work to understand the mechanisms that lead to the emergence of cancer; they and their teams develop new therapeutic approaches and new drugs to treat different forms of the disease.